Brph institucional junho v9 eng (site)

105 views

Published on

Published in: Business, Technology
  • Be the first to comment

  • Be the first to like this

Brph institucional junho v9 eng (site)

  1. 1. 2003200420052006200720082009201020112012e2013e2014e2015e2016e2017e2018e2019e2020e
  2. 2. -20% -10% 0% 10% 20%0 - 910 - 1920 - 2930 - 3940 - 4950 - 5960 - 6970 - 7980+Europe 2010 Brazil 2030-20% -10% 0% 10% 20%0 - 910 - 1920 - 2930 - 3940 - 4950 - 5960 - 6970 - 7980+Europe 2010 Brazil 2010
  3. 3. 113339095109 81 709
  4. 4. 
  5. 5. ••••••••••••••••
  6. 6. MAPPINGPLUG-INCONTINUOUSIMPROVEMENT123Admission to TerminationCalculation and CollectionCalculating ResultsAdministrative-FinancialAdministrative SupportIT SupportPASCenterSharedServices-SSC••
  7. 7. ••••••
  8. 8. •••••••••••••••
  9. 9. Dermocosmetics space to displayspremium productsGondola point:: Clusterizing stores by customerprofile to maximize potential of productsexposureCheck-out display: High turnover products toencourage impulse purchaseCategory management: Intelligence organizationdepending on consumption drive
  10. 10. 
  11. 11. EVOLUTION OF FARMAIS STORE BASEFARMAIS EXPANSION
  12. 12. •••
  13. 13. RESULTS
  14. 14. 124996 29152011 Aquisição Cresc. orgânico Fechamento Cresc. orgânico13221011824896 2915 2esc. orgânico Fechamento Cresc. orgânico Fechamento 2012113221011824824967 2913 22011 Acquisition Organic growth Closing 9M12 Organic growth Closing 2012378681 70813221011824824967 2913 22011 Acquisition Organic growth Closing 9M12 Organic growth Closing 2012378681 70813221011824824967 2913 22011 Acquisition Organic growth Closing 9M12 Organic growth Closing 2012378681 70813221011824824967 2913 22011 Acquisition Organic growth Closing 9M12 Organic growth Closing 2012378681 70813221011824824967 2913 22011 Acquisition Organic growth Closing 9M12 Organic growth Closing 2012378681 708378708
  15. 15. ²
  16. 16. Cash position and indebtedness (R$000) 1Q12 4Q12 1Q13(+) Loans and financing 344,487 177,049 169,079Short term 241,251 83,229 44,864Long term 103,236 93,820 124,215(+) Debentures - 253,642 258,937Short term - 5,237 10,427Long term - 248,405 248,510(+) Accounts payable for investment acquisition 347,212 345,333 264,430Short term 34,833 99,711 82,833Long term 312,379 245,622 181,597(=) Total Indebtedness 691,699 776,024 692,446Short term (%) 39.9% 24.2% 19.9%Long term (%) 60.1% 75.8% 80.1%(-) Cash and cash equivalents (122,901) (368,751) (183,870)(=) Net Debt 568,798 407,273 508,576Net debt/Adjusted EBITDA (LTM) 3.4 X 2.1 X 2.7 XWorking capial 4Q11 1Q12 4Q12 1Q13Accounts receivable 21 22 23 24Inventories 114 86 95 106Suppliers 62 63 58 55Working capital in days 72 45 60 75
  17. 17. •••••••••••
  18. 18. Jun-11Jul-11Aug-11Sep-11Oct-11Nov-11Dec-11Jan-12Feb-12Mar-12Apr-12May-12Jun-12Jul-12Aug-12Sep-12Oct-12Nov-12Dec-12Jan-13Feb-13Mar-13Apr-13May-13Jun-11Jul-11Aug-11Sep-11Oct-11Nov-11Dec-11Jan-12Feb-12Mar-12Apr-12May-12Jun-12Jul-12Aug-12Oct-12Nov-12Dec-12Jan-13Feb-13Mar-13Apr-13May-132013 2014Brasil Pharma 12,9x 10,0x2013 2014Brasil Pharma 0,9x 0,7x2013 2014Brasil Pharma 22,8x 16,8xEV/EBITDAEV/SalesP/E
  19. 19. 5.8 6.2 6.0 6.3 6.5 5.8 5.88.5 9.313.919.211.815.211.86.7 8.310.6 9.0 9.5 11.4 7.17.09.9 11.0 10.4 12.034.011.7 12.4 12.326.730.745.625.733.319.014.317.521.919.1 18.0 19.211.8 12.30100002000030000400005000060000010002000300040005000600070006.28.97.810.4 10.39.27.99.210.815.118.5 18.922.821.318.114.6 14.015.6 14.811.88.87.52111.416.214.219.2 18.916.614.116.218.624.630.4 29.837.534.829.92422.926.323.821.118.8010000200003000040000500001987198819891990199119921993199419951996199719981999200020012002200320042005200620070500100015002000250030003500400045000,010000,0198719881989199019911992199319941995199619971998199920002001200220032004200520062007market cap EV/EBITDA P/E0,01000,02000,0EBITDA

×